Sökning: WFRF:(Gaillard Pieter) > In vivo Functional ...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 03493naa a2200421 4500 | |
001 | oai:DiVA.org:uu-267583 | |
003 | SwePub | |
008 | 151124s2016 | |||||||||||000 ||eng| | |
024 | 7 | a https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-2675832 URI |
024 | 7 | a https://doi.org/10.1007/s11095-015-1774-32 DOI |
040 | a (SwePub)uu | |
041 | a engb eng | |
042 | 9 SwePub | |
072 | 7 | a ref2 swepub-contenttype |
072 | 7 | a art2 swepub-publicationtype |
100 | 1 | a Lindqvist, Annika,d 1983-u Uppsala universitet,Institutionen för farmaceutisk biovetenskap,Science for Life Laboratory, SciLifeLab,Translational PKPD4 aut0 (Swepub:uu)annbo297 |
245 | 1 0 | a In vivo Functional Evaluation of Increased Brain Delivery of the Opioid Peptide DAMGO by Glutathione-PEGylated Liposomes |
264 | c 2015-08-15 | |
264 | 1 | b Springer Science and Business Media LLC,c 2016 |
338 | a print2 rdacarrier | |
520 | a Purpose:The purpose of this study was to evaluate formulation factors causing improvement in brain delivery of a small peptide after encapsulation into a targeted nanocarrier in vivo.Methods:The evaluation was performed in rats using microdialysis, which enabled continuous sampling of the released drug in both the brain (striatum) and blood. Uptake in brain could thereby be studied in terms of therapeutically active, released drug.Results:We found that encapsulation of the peptide DAMGO in fast-releasing polyethylene glycol (PEG)ylated liposomes, either with or without the specific brain targeting ligand glutathione (GSH), doubled the uptake of DAMGO into the rat brain. The increased brain delivery was observed only when the drug was encapsulated into the liposomes, thus excluding any effects of the liposomes themselves on the blood-brain barrier integrity as a possible mechanism. The addition of a GSH coating on the liposomes did not result in an additional increase in DAMGO concentrations in the brain, in contrast to earlier studies on GSH coating. This may be caused by differences in the characteristics of the encapsulated compounds and the composition of the liposome formulations. Conclusions:We were able to show that encapsulation into PEGylated liposomes of a peptide with limited brain delivery could double the drug uptake into the brain without using a specific brain targeting ligand. | |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Medicinska och farmaceutiska grundvetenskaperx Farmaceutiska vetenskaper0 (SwePub)301012 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Basic Medicinex Pharmaceutical Sciences0 (SwePub)301012 hsv//eng |
653 | a Brain delivery | |
653 | a liposomes | |
653 | a blood-brain barrier | |
653 | a microdialysis | |
653 | a opioid peptide | |
653 | a Farmakokinetik och läkemedelsterapi | |
653 | a Pharmacokinetics and Drug Therapy | |
700 | 1 | a Rip, Jaap4 aut |
700 | 1 | a van Kregten, Joan4 aut |
700 | 1 | a Gaillard, Pieter J4 aut |
700 | 1 | a Hammarlund-Udenaes, Margaretau Uppsala universitet,Institutionen för farmaceutisk biovetenskap,Science for Life Laboratory, SciLifeLab,Translational PKPD4 aut0 (Swepub:uu)marghamm |
710 | 2 | a Uppsala universitetb Institutionen för farmaceutisk biovetenskap4 org |
773 | 0 | t Pharmaceutical researchd : Springer Science and Business Media LLCg 33:1, s. 177-185q 33:1<177-185x 0724-8741x 1573-904X |
856 | 4 8 | u https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-267583 |
856 | 4 8 | u https://doi.org/10.1007/s11095-015-1774-3 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
Kopiera och spara länken för att återkomma till aktuell vy